Nanotechnology in Vaccine Delivery

Authors

Martin J. D'Souza, Mercer University
Suprita A. Tawde, Akorn Inc.Follow
Archana Akalkotkar, Mercer University
Lipika Chablani, St. John Fisher UniversityFollow
Marissa D'Souza, Mercer University
Maurizio Chiriva-Internati, Texas Tech University Health Sciences Center

Document Type

Book Chapter

Publication Date

9-16-2013

Abstract

Immunotherapy has been a trusted therapy for centuries to eliminate infectious diseases. However, the successful immunotherapy depends on several factors such as nature of pathogen, vaccine delivery system, route of administration, and immune system of the host. With the advances in nanotechnology, immunotherapy is now targeting different challenging disorders including cancer as well as infectious diseases. Along with the evolution of several adjuvants to enhance immune response to vaccines, nanotechnology plays an important role by acting as self-adjuvant in form of particles.

DOI

10.1007/978-3-319-00978-0_19

Comments

Find this book on Amazon.

Find this book at your library.

Publication Information

D'Souza, Martin J.; Tawde, Suprita A.; Akalkotkar, Archana; Chablani, Lipika; D'Souza, Marissa; and Chiriva-Internati, Maurizio (2013). "Nanotechnology in Vaccine Delivery." Molecular Vaccines 2, 727-741.

Please note that the Publication Information provides general citation information and may not be appropriate for your discipline. To receive help in creating a citation based on your discipline, please visit http://libguides.sjfc.edu/citations.